Literature DB >> 9227479

Dual effects of PACAP on guinea pig gallbladder muscle via PACAP-preferring and VIP/PACAP-preferring receptors.

H P Parkman1, A P Pagano, J P Ryan.   

Abstract

The aims of this study were to determine the effect and mechanism of action of pituitary adenylate cyclase-activating peptide (PACAP) on gallbladder muscle. Guinea pig gallbladder muscle strips were studied isometrically. In noncontracted muscle strips, PACAP-27 and PACAP-38 caused dose-dependent contractions, whereas vasoactive intestinal peptide (VIP) caused dose-dependent relaxation. PACAP-27 contractions were resistant to tetrodotoxin, atropine, and the substance P receptor antagonist [D-Arg1,D-Trp7,9,Leu11]substance P (Spantide) but were inhibited by the selective PACAP receptor antagonist PACAP-(6-38) and slightly increased with the VIP receptor antagonist [4-chloro-D-Phe6,Leu17]VIP. In cholecystokinin-precontracted muscle strips, both VIP and PACAP caused relaxations. This relaxant effect of PACAP-27 was inhibited by PACAP-(6-38) and [4-chloro-D-Phe6,Leu17]VIP, but not by tetrodotoxin. These studies suggest that PACAP has dual excitatory and inhibitory effects on guinea pig gallbladder muscle. The contractile effect of PACAP is a direct action on muscle through PACAP-preferring receptors. The relaxant effect of PACAP is seen in precontracted muscle strips and mediated through VIP/ PACAP-preferring receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227479     DOI: 10.1152/ajpgi.1997.272.6.G1433

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Nitric oxide pathways in circular muscle of the rat jejunum before and after small bowel transplantation.

Authors:  B M Balsiger; J A Duenes; N Ohtani; C Shibata; G Farrugia; W J Anding; M G Sarr
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

2.  PACAP Modulates Acetylcholine-Elicited Contractions at Nicotinic Neuromuscular Contacts of the Land Snail.

Authors:  Nóra Krajcs; László Hernádi; Zsolt Pirger; Dóra Reglődi; Gábor Tóth; Tibor Kiss
Journal:  J Mol Neurosci       Date:  2015-07-03       Impact factor: 3.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.